Company intelligence / Profile preview
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Shenzhen, Guangdong, China999.com.cn ↗
- Ownership
- Public · 000999
- Employees
- ~20318
- Development stage
- Other
01
Overview
The company is a major player in the Chinese pharmaceutical industry, focusing on a wide range of therapeutic areas. It reported a net income of 1.27 billion yuan in the first quarter of 2025.
- Therapeutic areas
- OncologyOtherDermatologyRheumatologyGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small moleculesTraditional Chinese Medicine (TCM)Formula Granules
- Industry
- Biotech
02
Drug pipeline
38 assets37 more assets in the full pipeline.
03
Partnerships
Recent plans include acquiring a stake in Tasly Pharma Group.
04
Financials
- Market cap
- $6.5B
- Total revenue
- $4.7B
- Enterprise value
- $6.2B
Beyond the preview
Go deeper on China Resources Sanjiu Medical & Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China Resources Sanjiu Medical & Pharmaceutical Co., Ltd..